SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 44 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,252,647 | +4.1% | 5,198,000 | 0.0% | 0.20% | +6.5% |
Q2 2023 | $8,887,187 | -23.2% | 5,198,000 | -12.6% | 0.19% | -19.1% |
Q1 2023 | $11,571,045 | -83.9% | 5,948,000 | -84.5% | 0.23% | -86.6% |
Q4 2022 | $71,834,226 | +12.0% | 38,394,000 | 0.0% | 1.71% | +16.4% |
Q3 2022 | $64,158,000 | +423.5% | 38,394,000 | +667.9% | 1.47% | +326.1% |
Q4 2020 | $12,256,000 | +18.1% | 5,000,000 | 0.0% | 0.34% | -12.9% |
Q3 2020 | $10,382,000 | -39.8% | 5,000,000 | -33.3% | 0.40% | -49.2% |
Q2 2020 | $17,246,000 | +49.6% | 7,500,000 | 0.0% | 0.78% | +39.5% |
Q1 2020 | $11,527,000 | -50.7% | 7,500,000 | -37.5% | 0.56% | -55.4% |
Q4 2019 | $23,393,000 | -26.5% | 12,000,000 | -50.0% | 1.25% | -35.7% |
Q3 2019 | $31,832,000 | -64.3% | 24,000,000 | -40.0% | 1.95% | -56.6% |
Q2 2019 | $89,055,000 | +11.4% | 40,000,000 | -9.3% | 4.49% | -5.2% |
Q1 2019 | $79,962,000 | +8.2% | 44,113,000 | 0.0% | 4.74% | -2.9% |
Q4 2018 | $73,926,000 | – | 44,113,000 | – | 4.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DeepCurrents Investment Group LLC | 55,277,000 | $84,644,000 | 4.13% |
STEELHEAD PARTNERS LLC | 19,300,000 | $29,580,000 | 2.91% |
LINDEN ADVISORS LP | 95,377,000 | $145,892,000 | 2.59% |
WOLVERINE ASSET MANAGEMENT LLC | 89,141,000 | $136,310,000 | 1.98% |
Verition Fund Management LLC | 14,735,000 | $22,403,000 | 0.88% |
ADVENT CAPITAL MANAGEMENT /DE/ | 20,376,000 | $31,177,000 | 0.68% |
Nicholas Investment Partners, LP | 1,950,000 | $2,960,000 | 0.58% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 7,500,000 | $11,527,000 | 0.56% |
SSI INVESTMENT MANAGEMENT LLC | 3,009,000 | $4,572,000 | 0.40% |
Calamos Advisors LLC | 26,471,000 | $40,570,000 | 0.32% |